Literature DB >> 16513611

Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.

Yaichiro Hashimoto1, Tetsuya Tsujikawa, Chisato Kondo, Masako Maki, Mitsuru Momose, Atsushi Nagai, Takamasa Ohnuki, Toshio Nishikawa, Kiyoko Kusakabe.   

Abstract

UNLABELLED: Benign and malignant pulmonary lesions usually are differentiated by 18F-FDG PET with a semiquantitative 18F-FDG standardized uptake value (SUV) of 2.5. However, the frequency of malignancies with an SUV of <2.5 is significant, and pulmonary nodules with low 18F-FDG uptake often present diagnostic challenges.
METHODS: Among 360 consecutive patients who underwent 18F-FDG PET to evaluate pulmonary nodules found on CT, we retrospectively analyzed 43 who had solid pulmonary lesions (excluding lesions with ground-glass opacity, infiltration, or benign calcification) with an SUV of <2.5. The uptake of 18F-FDG was graded by a visual method (absent, faint, moderate, or intense) and 2 semiquantitative methods (SUV and contrast ratio [CR]). Final classification was based on histopathologic findings or at least 6 mo of clinical follow-up.
RESULTS: We found 16 malignant (diameter, 8-32 mm) and 27 benign (7-36 mm) lesions. When faint visual uptake was the cutoff for positive 18F-FDG PET results, the receiver-operating-characteristic (ROC) analysis correctly identified all 16 malignancies and yielded false-positive results for 10 of 27 benign lesions. Sensitivity was 100%, specificity was 63%, and the positive and negative predictive values were 62% and 100%, respectively. When an SUV of 1.59 was the cutoff for positive 18F-FDG PET results, the ROC analysis revealed 81% sensitivity, 85% specificity, and positive and negative predictive values of 77% and 89%, respectively. At a cutoff for positive 18F-FDG PET results of a CR of 0.29, the ROC analysis revealed 75% sensitivity, 82% specificity, and positive and negative predictive values of 71% and 85%, respectively. The areas under the curve in ROC analyses did not differ significantly among the 3 analyses (visual, 0.84; SUV, 0.81; and CR, 0.82). Analyses of intra- and interobserver variabilities indicated that visual and SUV analyses were quite reproducible, whereas CR analysis was poorly reproducible.
CONCLUSION: These results suggested that for solid pulmonary lesions with low 18F-FDG uptake, semiquantitative approaches do not improve the accuracy of 18F-FDG PET over that obtained with visual analysis. Pulmonary lesions with visually absent uptake indicate that the probability of malignancies is very low. In contrast, the probability of malignancy in any visually evident lesion is about 60%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513611

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  49 in total

1.  Use of ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography in a miniature pig (Sus scrofa domestica) with pneumonia.

Authors:  Jong-In Kim; Young Ah Lee; Jae Won Lee; Sang Min Jeong; Hyun Woo Chung; Jin Soo Han
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

2.  Initial clinical results for breath-hold CT-based processing of respiratory-gated PET acquisitions.

Authors:  Loïc Fin; Joël Daouk; Julie Morvan; Pascal Bailly; Isabelle El Esper; Lazhar Saidi; Marc-Etienne Meyer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-26       Impact factor: 9.236

3.  Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects.

Authors:  Hisanobu Koyama; Yoshiharu Ohno; Atsushi Kono; Daisuke Takenaka; Yoshimasa Maniwa; Yoshihiro Nishimura; Chiho Ohbayashi; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

Review 4.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

5.  (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.

Authors:  Ober van Gómez López; Ana María García Vicente; Antonio Francisco Honguero Martínez; Germán Andrés Jiménez Londoño; Carlos Hugo Vega Caicedo; Pablo León Atance; Ángel María Soriano Castrejón
Journal:  Transl Lung Cancer Res       Date:  2015-06

6.  [Combined use of thin-section CT and 18F-FDG PET/CT for characterization of solitary pulmonary nodules].

Authors:  Yun-Yan Ren; You-Cai Li; Hu-Bing Wu; Quan-Shi Wang; Yan-Jiang Han; Wen-Lan Zhou; Hong-Sheng Li; Zhen Wang; Mohammed Shah Alam Mohammed Shah Alam
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

7.  Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.

Authors:  Michael Frumovitz; Pedro T Ramirez; Homer A Macapinlac; Ann H Klopp; Alpa M Nick; Lois M Ramondetta; Anuja Jhingran
Journal:  Int J Gynecol Cancer       Date:  2012-09       Impact factor: 3.437

8.  PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.

Authors:  Yee Ting Sim; Yong Geng Goh; Mary Frances Dempsey; Sai Han; Fat Wui Poon
Journal:  Lung       Date:  2013-09-08       Impact factor: 2.584

9.  Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.

Authors:  Sandra Pauls; Andreas K Buck; Gisela Halter; Felix M Mottaghy; Rainer Muche; Christina Bluemel; Susanne Gerstner; Stefan Krüger; Gerhard Glatting; Ludger Sunder-Plassmann; Peter Möller; Hans-Jürgen Brambs; Sven N Reske
Journal:  Mol Imaging Biol       Date:  2008-01-16       Impact factor: 3.488

10.  Positron emission tomography in the management of lung cancer.

Authors:  Vahid Reza Dabbagh Kakhki
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.